Search Results

Return to List
Results 1–20 of 38
Title Date
1.

Aromatase Inhibitors in Gynecologic Practice

Number 663

(Replaces Committee Opinion Number 412, August 2008)

ABSTRACT Aromatase inhibitors have been used for the treatment of breast cancer ovulation induction endometriosis and other estrogenmodulated conditions For women with breast cancer bone mineral density screening is recommended with longterm aromatase inhibitor use because of risk of osteoporosis ...

June 2016

PDF Format
2.

Integrating Immunizations Into Practice

Number 661

ABSTRACT Immunization against vaccinepreventable diseases is an essential component of womens primary and preventive health care Despite the importance of vaccination and clear guidance from public health agencies rates of vaccination lag behind national goals Obstetriciangynecologists can play a ...

April 2016

PDF Format
3.

The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer

Number 659

ABSTRACT Cancer treatment should address femalespecific survivorship issues including the hypoestrogenicrelated adverse effects of cancer therapies or of natural menopause in survivors Systemic and vaginal estrogen are widely used for symptomatic relief of vasomotor symptoms sexual dysfunction and...

March 2016

PDF Format
4.

Magnesium Sulfate Use in Obstetrics

Number 652

(Replaces Committee Opinion Number 573, September 2013)

ABSTRACT The US Food and Drug Administration advises against the use of magnesium sulfate injections for more than 57 days to stop preterm labor in pregnant women Based on this the drug classification was changed from Category A to Category D and the labeling was changed to include this new warnin...

January 2016

PDF Format
5.

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Number 623

(Replaces Committee Opinion Number 514, December 2011)

ABSTRACT Acuteonset severe systolic hypertension severe diastolic hypertension or both can occur in pregnant women or women in the postpartum period Introducing standardized evidencebased clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to re...

February 2015

PDF Format
6.

Ovarian Reserve Testing

Number 618

ABSTRACT The main goal of ovarian reserve testing is to identify those individuals who are at risk of decreased or diminished ovarian reserve commonly known as DOR Although ovarian reserve testing cannot predict the end of ones reproductive years results outside the range expected for a patients a...

January 2015

PDF Format
7.

Chronic Antithrombotic Therapy and Gynecologic Surgery

Number 610

ABSTRACT Surgery can present a management dilemma for gynecologists whose patients receive chronic antithrombotic therapy because the risk of hemorrhagic complications must be balanced against the risk of thromboembolic complications Interruption of antithrombotic therapy to reduce perioperative b...

October 2014

PDF Format
8.

Influenza Vaccination During Pregnancy

Number 608

(Replaces Committee Opinion Number 468, October 2010)

ABSTRACT The Centers for Disease Control and Preventions Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend that all adults receive an annual influenza vaccine Influenza vaccination is an essential element of preconception prenatal an...

September 2014

PDF Format
9.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Number 606

ABSTRACT Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding and gynecologists may be consulted either before the initiation of cancer treatment to request strategies for menstrual suppression or during an episode of severe heavy bleeding to stop the bleeding emerg...

August 2014

PDF Format
10.

Primary Ovarian Insufficiency in Adolescents and Young Women

Number 605

(Reaffirmed 2016)

ABSTRACT Primary ovarian insufficiency is the depletion or dysfunction of ovarian follicles with cessation of menses before age 40 years There is no consensus on criteria to identify primary ovarian insufficiency in adolescents and delay in diagnosis is common Health care providers who make this c...

July 2014

PDF Format
11.

OnabotulinumtoxinA and the Bladder

Number 604

ABSTRACT In January 2013 the US Food and Drug Administration approved the use of onabotulinumtoxinA also known as Botox A for the treatment of overactive bladder thus providing another treatment option for women Symptoms of overactive bladder have been shown to significantly improve after onabotul...

June 2014

PDF Format
12.

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT Tamoxifen a nonsteroidal antiestrogen agent is widely used as adjunctive therapy for women with breast cancer and it has been approved by the US Food and Drug Administration for adjuvant treatment of breast cancer treatment of metastatic breast cancer and reduction in breast cancer incide...

June 2014

PDF Format
13.

Labor Induction or Augmentation and Autism

Number 597

Abstract Functional oxytocin deficiency and a faulty oxytocin signaling pathway have been observed in conjunction with autism spectrum disorder ASD Because exogenous synthetic oxytocin commonly is administered for labor induction and augmentation some have hypothesized that synthetic oxytocin used...

May 2014

PDF Format
14.

Preexposure Prophylaxis for the Prevention of Human Immunodeficiency Virus

Number 595

Abstract Preexposure prophylaxis is defined as the administration of antiretroviral medications to individuals who are not infected with human immunodeficiency virus HIV and are at the highest risk of acquiring HIV infection In combination with other proven HIVprevention methods preexposure prophy...

May 2014

PDF Format
15.

Solutions for Surgical Preparation of the Vagina

Number 571

(Reaffirmed 2015)

ABSTRACT Currently only povidoneiodine preparations are approved for vaginal surgicalsite antisepsis However there are compelling reasons to consider chlorhexidine gluconate solutions for offlabel use in surgical preparation of the vagina especially in women with allergies to iodine Although chlor...

September 2013

PDF Format
16.

Update on Immunization and Pregnancy Tetanus Diphtheria and Pertussis Vaccination

Number 566

(Replaces No. 521, March 2012, Reaffirmed 2015)

ABSTRACT In the face of dramatic and persistent increases in pertussis disease in the United States the Centers for Disease Control and Preventions Advisory Committee on Immunization Practices has updated its guidelines for the use of the tetanus toxoid reduced diphtheria toxoid and acellular pert...

June 2013

PDF Format
17.

Ethical Issues With Vaccination for the Obstetrician–Gynecologist

Number 564

(Reaffirmed 2016)

ABSTRACT Because of the growing importance of infectious disease prevention in the individual patient and the larger community it is vital that Fellows of the American College of Obstetricians and Gynecologists be prepared to navigate the practical and ethical challenges that come with vaccination...

May 2013

PDF Format
18.

Ethical Issues in Pandemic Influenza Planning Concerning Pregnant Women

Number 563

ABSTRACT Pregnant women traditionally have been assigned priority in the allocation of prevention and treatment resources during outbreaks of influenza because of their increased risk of morbidity and mortality The Committee on Ethics of the American College of Obstetricians and Gynecologists expl...

May 2013

PDF Format
19.

Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women

Number 557

(Reaffirmed 2015)

ABSTRACT Initial evaluation of the patient with acute abnormal uterine bleeding should include a prompt assessment for signs of hypovolemia and potential hemodynamic instability After initial assessment and stabilization the etiologies of acute abnormal uterine bleeding should be classified using ...

April 2013

PDF Format
20.

Postmenopausal Estrogen Therapy: Route of Administration and Risk of Venous Thromboembolism

Number 556

(Reaffirmed 2015)

ABSTRACT The development of menopausal symptoms and related disorders which lead women to seek prescriptions for postmenopausal estrogen therapy and hormone therapy is a common reason for a patient to visit her gynecologist but these therapies are associated with an increased risk of venous thromb...

April 2013

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998